Dave Ricks

2 results

Loxo is developing cancer treatments that target a tumors’ genetic markers regardless of where in the body they’re located

US pharma giant Eli Lilly is to buy Loxo Oncology for about $8 billion (€7 billion) in cash, the second multibillion-dollar cancer deal of the year by(...)

Earnings at Eil Lilly were 95 cents a share. Photograph: Reuters

Pharma giant Eli Lilly reported fourth-quarter profit that missed analysts’ estimates, after sales of some of its older drugs declined. Earnings wer(...)